For Immediate Release

ST. LOUIS/EWORLDWIRE/Dec. 19, 2005 --- On October 4, LegalMetric LLC announced a 57 percent probability of a decision in the Lipitor patent case by the end of January, with "a significant possibility of an earlier decision." That announcement also included the results of LegalMetric's analysis which indicated an increase in Pfizer stock price "in the neighborhood of 10 percent" if the decision was favorable to Pfizer. Judge Farnan issued his ruling Friday, December 16, 2005 and as of Monday morning, December 19, 2005, the stock price increase was 11 percent.

LegalMetric, a litigation data mining company in St. Louis, is making its studies of patent cases available to the financial industry and the investing public. Each litigation report covers a single patent case (or group of cases concerning a particular product) and includes likely outcomes (based upon previous outcomes before the presiding judge and court), the range of time to decision for various outcomes and the likely effect on the stock price of the patent owner (or the accused infringer). Litigation reports are $895, with monthly updates available for $95 per month per case.

HTML:   http://www.eworldwire.com/pressreleases/13337
PDF:   http://www.eworldwire.com/pdf/13337.pdf
MOBILE:    http://e4mobile.com/view_release.php?id=13337
ONLINE NEWSROOM:   http://www.eworldwire.com/newsroom/307689.htm
NEWSROOM RSS FEED:   http://newsroom.eworldwire.com/xml/newsrooms/307689.xml
LOGO:   http://www.eworldwire.com/newsroom/307689.htm

CONTACT:
Phil Meisinger
LegalMetric, LLC
St. Louis, MO
PHONE. 1-888-309-3001 x2
FAX. 1-888-309-3002
EMAIL: phil@legalmetric.com
http://www.legalmetric.com

SOURCE: LegalMetric, LLC